Skip to main content
. 2022 Mar 15;66(3):e02206-21. doi: 10.1128/aac.02206-21

TABLE 1.

Antifungal susceptibility testing (includes single agents and combinations) for clinical isolate of Aspergillus calidoustus

Antifungal MIC (μg/mL) MIC (μg/mL)
Single agents
 Micafungin 0.5
 Posaconazole >4
 Voriconazole >4
 Isavuconazole >4
 Terbinafine 0.5
 Amphotericin (AMB) 1
 Fosmanogepix ≤0.008
Synergy testing
 AMB + micafungin 1 ≤0.03
 AMB + posaconazole 1 ≤0.03
 AMB + voriconazole 1 ≤0.03
 AMB + terbinafine 1 ≤0.015
 AMB + isavuconazole 1 ≤0.03
 Isavuconazole + terbinafine ≤0.03 0.5